Specifically targeted drug delivery systems with low immunogenicity and toxicity are deemed to increase efficacy of cancer chemotherapy. Acridine Orange (AO) is an acidophilic dye with a strong tumoricidal action following excitation with a light source at 466 nm. However, to date the clinical use of AO is limited by the potential side effects elicited by systemic administration. The endogenous nanocarrier exosomes have been recently introduced as a natural delivery system for therapeutic molecules. In this article, we show the outcome of the administration to human melanoma cells of AO charged Exosomes (Exo-AO), in both monolayer and spheroid models. The results showed an extended drug delivery time of Exo-AO to melanoma cells as compared to the free AO, improving the cytotoxicity of AO. This study shows that Exo- AO have a great potential for a real exploitation as a new theranostic approach against tumors based on AO delivered through the exosomes.
|Number of pages||10|
|Journal||Journal of Enzyme Inhibition and Medicinal Chemistry|
|Publication status||Published - Jan 1 2017|
- Acridine orange
- Delivery system
ASJC Scopus subject areas
- Drug Discovery